UK markets closed
  • FTSE 100

    6,893.81
    +12.22 (+0.18%)
     
  • FTSE 250

    17,168.34
    +377.94 (+2.25%)
     
  • AIM

    806.38
    +7.99 (+1.00%)
     
  • GBP/EUR

    1.1381
    +0.0057 (+0.50%)
     
  • GBP/USD

    1.1166
    +0.0043 (+0.38%)
     
  • BTC-GBP

    17,344.47
    -278.72 (-1.58%)
     
  • CMC Crypto 200

    443.49
    +0.06 (+0.01%)
     
  • S&P 500

    3,585.62
    -54.85 (-1.51%)
     
  • DOW

    28,725.51
    -500.10 (-1.71%)
     
  • CRUDE OIL

    79.74
    -1.49 (-1.83%)
     
  • GOLD FUTURES

    1,668.30
    -0.30 (-0.02%)
     
  • NIKKEI 225

    25,937.21
    -484.84 (-1.83%)
     
  • HANG SENG

    17,222.83
    +56.96 (+0.33%)
     
  • DAX

    12,114.36
    +138.81 (+1.16%)
     
  • CAC 40

    5,762.34
    +85.47 (+1.51%)
     

The global endoluminal suturing devices market is projected to reach USD 139 million by 2027 from USD 78 million in 2022, at a CAGR of 12.0%

·3-min read
ReportLinker
ReportLinker

The growth of this market can largely be attributed to the rising demand for bariatric surgeries, increasing number of surgeries, and rising prevalence of gastrointestinal diseases. The gastrointestinal surgery segment is expected to register the highest CAGR during the forecast period

New York, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Endoluminal Suturing Devices Market by Application, End User, Technology Analysis, Regulatory Landscape, Trends - Global Forecast to 2027" - https://www.reportlinker.com/p06319114/?utm_source=GNW
Based on application, the global endoluminal suturing devices market is segmented into bariatric surgery, gastrointestinal surgery, gastroesophageal reflux disease surgery, and other surgeries.The gastrointestinal surgery segment is expected to register the highest growth during the forecast period.

This is mainly due to the growing number of gastrointestinal cancer cases worldwide.

The ambulatory care centers segment to witness the highest growth in the endoluminal suturing devices end user market during the forecast period
Based on end users, the endoluminal suturing devices market is segmented into hospitals, ambulatory surgical centers, clinics, and other end users.The ambulatory care centers segment is expected to register the highest growth during the forecast period.

This can be attributed to the increased adoption of getting treated in ambulatory care settings due to the cost-effective treatment offered.

The APAC to witness the highest growth during the forecast period.
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2022–2027. The presence of high-growth markets such as India, China, and Japan, rapidly developing healthcare industry in China and India, increasing number of hospitals, rising per capita income, increasing healthcare infrastructure, rising burden of GI cancer, and the rising awareness about health are some of the major factors that are expected to drive the growth of the endoluminal suturing devices market in the Asia Pacific region.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–40%, Europe–30%, Asia Pacific–20%, Latin America- 5%, Middle East and Africa–5%

Key players in the Endoluminal suturing devices market
The prominent players in the endoluminal suturing devices market are Apollo Endosurgery, Inc. (US), Johnson & Johnson (US), Medtronic Plc (Ireland), Cook Group Incorporated (US), USGI Medical (US), Ovesco Endoscopy AG (Germany), Endo Tools Therapeutics S.A. (Belgium), ErgoSuture (US), and Sutrue Ltd. (UK).

Research Coverage:
The report analyzes the endoluminal suturing devices market and aims at estimating the market size and future growth potential of this market based on various segments such as, application, and end user.The report also includes a product portfolio matrix of various endoluminal suturing devices available in the market.

The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the endoluminal suturing devices market. The report analyzes this market by application and by end user.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global endoluminal suturing devices market.
• Market Development: Comprehensive information on the lucrative emerging markets by application and by end user.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global endoluminal suturing devices market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global endoluminal suturing devices market.
Read the full report: https://www.reportlinker.com/p06319114/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001